These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 20813060)

  • 101. Partial Ablation of Postsynaptic Dopamine D2 Receptors in the Central Nucleus of the Amygdala Increases Risk Avoidance in Exploratory Tasks.
    Casey E; Avale ME; Kravitz A; Rubinstein M
    eNeuro; 2022; 9(2):. PubMed ID: 35210287
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis.
    Seeman P; Weinshenker D; Quirion R; Srivastava LK; Bhardwaj SK; Grandy DK; Premont RT; Sotnikova TD; Boksa P; El-Ghundi M; O'dowd BF; George SR; Perreault ML; Männistö PT; Robinson S; Palmiter RD; Tallerico T
    Proc Natl Acad Sci U S A; 2005 Mar; 102(9):3513-8. PubMed ID: 15716360
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Imaging extra-striatal dopamine D2 receptors in a maternal immune activation rat model.
    Oh-Nishi A; Nagai Y; Seki C; Suhara T; Minamimoto T; Higuchi M
    Brain Behav Immun Health; 2022 Jul; 22():100446. PubMed ID: 35496774
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Effect of C-Terminal S-Palmitoylation on D2 Dopamine Receptor Trafficking and Stability.
    Ebersole B; Petko J; Woll M; Murakami S; Sokolina K; Wong V; Stagljar I; Lüscher B; Levenson R
    PLoS One; 2015; 10(11):e0140661. PubMed ID: 26535572
    [TBL] [Abstract][Full Text] [Related]  

  • 105. On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D
    Weidenauer A; Bauer M; Sauerzopf U; Bartova L; Nics L; Pfaff S; Philippe C; Berroterán-Infante N; Pichler V; Meyer BM; Rabl U; Sezen P; Cumming P; Stimpfl T; Sitte HH; Lanzenberger R; Mossaheb N; Zimprich A; Rusjan P; Dorffner G; Mitterhauser M; Hacker M; Pezawas L; Kasper S; Wadsak W; Praschak-Rieder N; Willeit M
    Transl Psychiatry; 2020 Jan; 10(1):2. PubMed ID: 32066718
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Novel D
    Juza R; Vojtechova I; Stefkova-Mazochova K; Dehaen W; Petrasek T; Prchal L; Kobrlova T; Janousek J; Vlcek P; Mezeiova E; Svozil D; Karasova JZ; Pejchal J; Stark H; Satala G; Bojarski AJ; Kubacka M; Mogilski S; Randakova A; Musilek K; Soukup O; Korabecny J
    Eur J Med Chem; 2022 Mar; 232():114193. PubMed ID: 35176563
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Prolonged Amphetamine Exposures Increase the Endogenous Human Dopamine Receptors 2 at the Cellular Membrane in Cells Lacking the Dopamine Transporter.
    Nawaratne V; McLaughlin SP; Mayer FP; Gichi Z; Mastriano A; Carvelli L
    Front Cell Neurosci; 2021; 15():681539. PubMed ID: 34512264
    [TBL] [Abstract][Full Text] [Related]  

  • 108. The effect of selective nigrostriatal dopamine excess on behaviors linked to the cognitive and negative symptoms of schizophrenia.
    Moya NA; Yun S; Fleps SW; Martin MM; Nadel JA; Beutler LR; Zweifel LS; Parker JG
    Neuropsychopharmacology; 2023 Mar; 48(4):690-699. PubMed ID: 36380221
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Dissociation of hedonic reaction to reward and incentive motivation in an animal model of the negative symptoms of schizophrenia.
    Ward RD; Simpson EH; Richards VL; Deo G; Taylor K; Glendinning JI; Kandel ER; Balsam PD
    Neuropsychopharmacology; 2012 Jun; 37(7):1699-707. PubMed ID: 22414818
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Dopamine Dynamics and Neurobiology of Non-Response to Antipsychotics, Relevance for Treatment Resistant Schizophrenia: A Systematic Review and Critical Appraisal.
    Iasevoli F; Avagliano C; D'Ambrosio L; Barone A; Ciccarelli M; De Simone G; Mazza B; Vellucci L; de Bartolomeis A
    Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979877
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Dopamine and glutamate in schizophrenia: biology, symptoms and treatment.
    McCutcheon RA; Krystal JH; Howes OD
    World Psychiatry; 2020 Feb; 19(1):15-33. PubMed ID: 31922684
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Chronic N-Acetylcysteine Treatment Prevents Amphetamine-Induced Hyperactivity in Heterozygous
    Lai CC; Baskaran R; Tsao CY; Tuan LH; Siow PF; Palani M; Lee LJ; Liu CM; Hwu HG; Lee LJ
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012679
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Design of a True Bivalent Ligand with Picomolar Binding Affinity for a G Protein-Coupled Receptor Homodimer.
    Pulido D; Casadó-Anguera V; Pérez-Benito L; Moreno E; Cordomí A; López L; Cortés A; Ferré S; Pardo L; Casadó V; Royo M
    J Med Chem; 2018 Oct; 61(20):9335-9346. PubMed ID: 30257092
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Potential Mechanisms for Why Not All Antipsychotics Are Able to Occupy Dopamine D
    Kiss B; Krámos B; Laszlovszky I
    Front Psychiatry; 2022; 13():785592. PubMed ID: 35401257
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Functional Reconstitution of Dopamine D2 Receptor into a Supported Model Membrane in a Nanometric Confinement.
    Nagai R; Sugimachi A; Tanimoto Y; Suzuki KGN; Hayashi F; Weikert D; Gmeiner P; Kasai RS; Morigaki K
    Adv Biol (Weinh); 2021 Dec; 5(12):e2100636. PubMed ID: 34761565
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Pharmacology of hallucinations: several mechanisms for one single symptom?
    Rolland B; Jardri R; Amad A; Thomas P; Cottencin O; Bordet R
    Biomed Res Int; 2014; 2014():307106. PubMed ID: 24991548
    [TBL] [Abstract][Full Text] [Related]  

  • 117. PCM1 is necessary for focal ciliary integrity and is a candidate for severe schizophrenia.
    Monroe TO; Garrett ME; Kousi M; Rodriguiz RM; Moon S; Bai Y; Brodar SC; Soldano KL; Savage J; Hansen TF; Muzny DM; Gibbs RA; Barak L; Sullivan PF; Ashley-Koch AE; Sawa A; Wetsel WC; Werge T; Katsanis N
    Nat Commun; 2020 Nov; 11(1):5903. PubMed ID: 33214552
    [TBL] [Abstract][Full Text] [Related]  

  • 118. The neurochemical pathology of schizophrenia: post-mortem studies from dopamine to parvalbumin.
    Reynolds GP
    J Neural Transm (Vienna); 2022 Jun; 129(5-6):643-647. PubMed ID: 34935080
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Association between dopamine receptor D2
    Olasore HSA; Oyedeji TA; Faleti JO; Ogundele OI; Olashore AA
    SAGE Open Med; 2024; 12():20503121241241922. PubMed ID: 38751571
    [TBL] [Abstract][Full Text] [Related]  

  • 120. The World of GPCR dimers - Mapping dopamine receptor D
    Bueschbell B; Magalhães PR; Barreto CAV; Melo R; Schiedel AC; Machuqueiro M; Moreira IS
    Comput Struct Biotechnol J; 2023; 21():4336-4353. PubMed ID: 37711187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.